Mousavi-roknabadi RS, Momennasab M, Askarian M, Haghshenas A, Marjadi B. Causes of medical errors and its under-reporting amongst pediatric nurses in Iran: a qualitative study. Int J Qual Health Care. 2019;31(7):541-6. .
Musharyanti L, Claramita M, Haryanti F, Dwiprahasto I. Why do nursing students make medication errors? A qualitative study in Indonesia. J Taibah Univ Med Sci. 2019;14(3):282-8.
Bates DW, Boyle DL, Vander Vliet MB, Schneider J, Leape L. Relationship between medication errors and adverse drug events. J Gen Intern Med. 1995;10:199-205.
Kass-Bartelmes BL. Reducing and preventing adverse drug events to decrease hospital costs. Res Action. 2001;1:1-20.
Segal G, Segev A, Brom A, Lifshitz Y, Wasserstrum Y, Zimlichman E. Reducing drug prescription errors and adverse drug events by application of a probabilistic, machine-learning based clinical decision support system in an inpatient setting. J Am Med Inform Associ. 2019;26(12):1560-5.
Ayvaz S, Horn J, Hassanzadeh O, Zhu Q, Stan J, Tatonetti NP, et al. Toward a complete dataset of drug–drug interaction information from publicly available sources. J Biomed Inform. 2015;55:206-17.
Mousavi S, Ghanbari G. Potential drug-drug interactions among hospitalized patients in a developing country. Caspian J Int Med. 2017;8(4):282.
Vonbach P, Dubied A, Krähenbühl S, Beer JH. Prevalence of drug–drug interactions at hospital entry and during hospital stay of patients in internal medicine. Eur J Int Med. 2008;19(6):413-20.
Patel VK, Acharya LD, Rajakannan T, Surulivelrajan M, Guddattu V, Padmakumar R. Potential drug interactions in patients admitted to cardiology wards of a south Indian teaching hospital. Australa Med J. 2011;4(1):9.
Ryu JY, Kim HU, Lee SY. Deep learning improves prediction of drug–drug and drug–food interactions. Proceed National Acad Sci. 2018;115(18):E4304-11.
Hammes JA, Pfuetzenreiter F, Silveira F, Koenig A, Westphal GA. Potential drug interactions prevalence in intensive care units. Rev Bras Ter Intensiva. 2008;20(4):349-54.
Mehralian HA, Moghaddasi J, Rafiei H. The prevalence of potentially beneficial and harmful drug-drug interactions in intensive care units. Drug Metab Personalized Ther. 2019;34(1). .
Cai R, Liu M, Hu Y, Melton BL, Matheny ME, Xu H, et al. Identification of adverse drug-drug interactions through causal association rule discovery from spontaneous adverse event reports. Artificial Intelligence Medicine. 2017;76:7-15.
Lima FE, Cassiani SH. Potential drug interaction in intensive care patients at a teaching hospital. Rev Latino-am Enfermagem. 2009;17(2):222-7.
Murtaza G, Khan MY, Azhar S, Khan SA, Khan TM. Assessment of potential drug–drug interactions and its associated factors in the hospitalized cardiac patients. Saudi Pharm J. 2016;24(2):220-5.
Diksis N, Melaku T, Assefa D, Tesfaye A. Potential drug–drug interactions and associated factors among hospitalized cardiac patients at Jimma University Medical Center, Southwest Ethiopia. SAGE open medicine. 2019;7:2050312119857353.
Bogetti-Salazar M, González-González C, Juárez-Cedillo T, Sánchez-García S, Rosas-Carrasco O. Severe potential drug-drug interactions in older adults with dementia and associated factors. Clinics. 2016;71(1):17-21.
Zheng WY, Richardson LC, Li L, Day RO, Westbrook JI, Baysari MT. Drug-drug interactions and their harmful effects in hospitalised patients: a systematic review and meta-analysis. Eur J Clin Pharmacol. 2018;74(1):15-27.
Cruciol-Souza JM, Thomson JC. Prevalence of potential drug-drug interactions and its associated factors in a Brazilian teaching hospital. J Pharm Pharm Sci. 2006;9(3):427-33.
Bjerrum L, Andersen M, Petersen G, Kragstrup J. Exposure to potential drug interactions in primary health care. Scand J Primary Health Care. 2003;21(3):153-8.
Rafiei H, Esmaeili Abdar M, Moghadasi J. The Prevalence of Potential Drug Interactions Among Critically Ill Elderly Patients in the Intensive Care Unit (ICU). Salmand: Iranian Journal of Ageing. 2012;6(4):14-19.
Abbasi Nazari M and Khanzadeh-Moqhadam N. Evaluation of pharmacokinetic drug interactions in prescriptions of intensive care unit (ICU) in a teaching hospital. Iran J Pharm Res. 2006:3215-18.
Almeida SM, Gama CS, Akamine N. Prevalence and classification of drug-drug interactions in intensive care patients. Einstein. 2007;5(4):347-51.
Sánchez-Fidalgo S, Guzmán-Ramos MI, Galván-Banqueri M, et al. Prevalence of drug interactions in elderly patients with multimorbidity in primary care. Int J Clin Pharm. 2017;39:343-53.
Holm J, Eiermann B, Eliasson E, et al. A limited number of prescribed drugs account for the great majority of drug-drug interactions. Eur J Clin Pharmacol 2014;70:1375-83.
Namazi S, Pourhatami S, Borhani-Haghighi A, Roosta S. Incidence of potential drug-drug interaction and related factors in hospitalized neurological patients in two Iranian teaching hospitals. Iran J Med Sci. 2014;39(6):515.
Reimche L, Forster AJ, van Walraven C. Incidence and contributors to potential drug-drug interactions in hospitalized patients. J Clin Pharmacol. 2011;51:1043-50.
Leucuta SE, Vlase L. Pharmacokinetics and metabolic drug interactions. Curr Clin Pharmacol. 2006;1:5-20.
Aghajani MH, Sistanizad M, Abbasinazari M, Ghamsari MA, Ayazkhoo L, Safi O, Kazemi K, Kouchek M. Potential drug-drug interactions in post-CCU of a teaching hospital. Iran J Pharm Res. 2013;12(1):243.